Klaudia Purgał-Zaborowska

Klaudia Purgał-Zaborowska

Auto-generated profile, based on publicly available information

Klaudia Purgał-Zaborowska

Poznan University of Medical Sciences, Poznan, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MZMichal Zaborowski
Michal Zaborowski
KPKlaudia Purgal-Zaborowska
Klaudia Purgal-Zaborowska
KMKlaudia Michalowska
Klaudia Michalowska
OKOliwier Kolanowski
Oliwier Kolanowski
MWMatuesz Winkler
Matuesz Winkler
OTOlga Turzanska
Olga Turzanska
Background. Total hip arthroplasty is one of the most frequently performer procedures by orthopaedic surgeons, choosing the right approach is an important component of the result of the operation. Minimally invasive approaches have an increasing share in orthopedic surgery and their use is becoming more and more common, but they have some limitations and therefore classical methods are still used. AIM. The aim of the review is to discuss and compare classical methods and minimally invasive methods, taking into account the advantages and limitations of the methods, the incidence of complications and the final result of treatment. Methods and Materials. A descriptive literature review was conducted using the PubMed and Google Scholar search engines in order to compare surgical approaches to hip arthroplasty. Results. Classic accesses allow better access to the operating field, but this is associated with high tissue trauma, which prolongs recovery in a short time after surgery. Complications are rare, but the method used determines the frequency of their occurrence. On the other hand, minimally invasive methods are associated with much less tissue traumatization, which results in faster recovery compared to classic methods, However, you have to take into account the limited operating field, which may be associated with a limitation of their use in obese people or in the case of revision surgeries. Conclusions. The choice of surgical approach in THA should be individual for each patient and should take into account the patient's anatomy, comorbidities and the surgeon's experience. Literature data indicate that minimally invasive accesses are characterized by a lower rate of complications, faster recovery and allow for faster hospital exit, but in long-term follow-up after surgery, the differences between MIA and classic approaches are statistically insignificant.

30 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
JBJulia Bezak
Julia Bezak
MWMateusz Winkler
Mateusz Winkler
AAAleksandra Arczewska
Aleksandra Arczewska
MSMagdalena Stolarczyk
Magdalena Stolarczyk
KPKlaudia Purgał-Zaborowska
Klaudia Purgał-Zaborowska
Background. Syphilis is not a disease we fail to cure; it is a disease we fail to prevent. Caused by Treponema pallidum and fully susceptible to penicillin, it should not be resurging. Yet over the past decade, syphilis has re-established itself as a global public health threat, with rising incidence and a striking resurgence of congenital syphilis- an outcome that exposes systemic gaps in maternal care and surveillance. Aim. This review interprets recent global shifts in syphilis epidemiology and evaluates advances in preclinical syphilis vaccine development to clarify the prospects for future prevention. Material and methods. A narrative review was conducted using PubMed, Scopus, and MDPI databases (2015-2025), and supplemented by surveillance reports from the official websites of international agencies, including the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC). Sources were selected for epidemiological relevance or substantive contributions to vaccine research. Results. Across regions, evidence consistently demonstrates sustained increase in syphilis and congenital syphilis rates. Preclinical vaccine studies have yielded promising immunogenicity and partial protection in animal models; however, no candidate has entered human trials, as key antigenic and translational barriers persist. Conclusions. The contemporary rise of syphilis reflects health-system fragility rather than therapeutic limitation. While vaccines may eventually augment prevention efforts, immediate progress depends on strengthening surveillance, ensuring universal antenatal screening, and closing the structural gaps that allow a curable infection to continue to spread.

14 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
JBJulia Bezak
Julia Bezak
MWMateusz Winkler
Mateusz Winkler
AAAleksandra Arczewska
Aleksandra Arczewska
MZMichał Zaborowski
Michał Zaborowski
OKOliwier Kolanowski
Oliwier Kolanowski
Spinal muscular atrophy (SMA) is a rare, autosomal recessive neuromuscular disorder caused by mutations or deletions in the SMN1 gene, leading to progressive motor neuron degeneration and muscle weakness. Nusinersen, an antisense oligonucleotide designed to modify SMN2 pre-mRNA splicing and increase functional SMN protein production, represents the first disease-modifying therapy approved for 5q SMA. This review summarizes evidence from pivotal clinical trials, including ENDEAR, CHERISH, EMBRACE, and DEVOTE, as well as real-world data in pediatric and adult populations. Across phenotypes, nusinersen has demonstrated clinically meaningful improvements or stabilization of motor function and increased survival free from permanent ventilation, particularly when initiated early in the disease course. Evidence suggests that treatment response may vary depending on baseline functional status and timing of therapy initiation. Despite proven efficacy, challenges remain, including limited long-term follow-up data, lack of direct head-to-head comparisons with other disease-modifying therapies, and variability in global accessibility due to economic and infrastructural factors. Additionally, manufacturing complexity and high production costs of antisense oligonucleotides influence healthcare system sustainability. Ongoing research focused on dosing optimization, long-term outcomes, and advances in oligonucleotide synthesis technologies may further refine the role of nusinersen within the evolving therapeutic landscape of SMA.

30 June 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MWMateusz Winkler
Mateusz Winkler
JBJulia Bezak
Julia Bezak
AAAleksandra Arczewska
Aleksandra Arczewska
MZMichał Zaborowski
Michał Zaborowski
KPKlaudia Purgał-Zaborowska
Klaudia Purgał-Zaborowska
SMSzymon Marciszuk
Szymon Marciszuk
Chimeric antigen receptor T-cell (CAR-T) therapy represents a major advancement in cancer immunotherapy, introducing a novel therapeutic approach based on the genetic modification of T lymphocytes to enhance tumor-specific cytotoxicity. This strategy has significantly transformed the treatment landscape, particularly in hematologic malignancies. The aim of this review is to summarize the current state of knowledge regarding CAR-T therapy, including its mechanisms of action, clinical applications, toxicity profile, limitations, and future directions of development. A narrative review of the literature was conducted based on selected publications indexed in biomedical databases, with particular emphasis on recent advances in both hematologic and solid tumors. CAR-T therapy has demonstrated high clinical efficacy in hematologic malignancies, especially B-cell cancers such as acute lymphoblastic leukemia and multiple myeloma, achieving substantial response rates in patients with relapsed or refractory disease. In contrast, its application in solid tumors remains limited due to challenges including antigen heterogeneity, an immunosuppressive tumor microenvironment, and reduced T-cell infiltration. The therapy is associated with characteristic toxicities, most notably cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, which require careful monitoring and management. Furthermore, its broader implementation is constrained by complex manufacturing processes, high costs, and limited accessibility. Ongoing research focuses on improving CAR-T cell persistence, overcoming T-cell exhaustion, optimizing antigen targeting, and developing novel strategies such as allogeneic products and combination therapies. In conclusion, CAR-T therapy constitutes a transformative modality in modern oncology, with established efficacy in hematologic malignancies and emerging potential in solid tumors, and its continued development is expected to further expand its clinical utility.

18 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
JBJulia Bezak
Julia Bezak
MWMateusz Winkler
Mateusz Winkler
AAAleksandra Arczewska
Aleksandra Arczewska
MZMichał Zaborowski
Michał Zaborowski
OTOlga Turzańska
Olga Turzańska
Obesity is one of the most significant public health challenges of the 21st century, with its prevalence continuously increasing worldwide. This condition is associated with an elevated risk of numerous metabolic, cardiovascular, and respiratory complications, leading to a substantial burden on healthcare systems. The pathophysiology of obesity is multifactorial and involves complex interactions between genetic, environmental, and neuroendocrine mechanisms regulating energy balance. Gastrointestinal hormones, including leptin, ghrelin, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP), play a crucial role in the regulation of appetite and metabolism. The aim of this study is to present current knowledge on the pathophysiology of obesity and to review contemporary and emerging treatment strategies. The article discusses classical therapeutic approaches, including lifestyle modification, dietary interventions, increased physical activity, and surgical treatment. Particular attention is given to modern pharmacological therapies targeting the incretin system. In recent years, significant progress has been made in the pharmacological treatment of obesity with the introduction of GLP-1 receptor agonists, such as semaglutide, as well as dual-acting agents, including tirzepatide, which acts as an agonist of both GLP-1 and GIP receptors. These therapies demonstrate high efficacy in body weight reduction by influencing central mechanisms of appetite regulation, delaying gastric emptying, and improving glucose metabolism. Furthermore, promising directions in obesity treatment are discussed, including triple incretin receptor agonists such as retatrutide, as well as combination therapies utilizing amylin analogues, for example CagriSema. In conclusion, the development of modern pharmacological therapies is significantly transforming the approach to obesity treatment and may in the future enable outcomes comparable to bariatric surgery. The integration of novel pharmacological methods with comprehensive lifestyle modification may represent the key to more effective management of obesity and reduction of its metabolic and cardiovascular complications.

11 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Weronika Kacperczyk
Julia Weronika Kacperczyk
JBJulia Bezak
Julia Bezak
MWMateusz Winkler
Mateusz Winkler
AAAleksandra Arczewska
Aleksandra Arczewska
MZMichał Zaborowski
Michał Zaborowski
OTOlga Turzańska
Olga Turzańska
Post-traumatic stress disorder (PTSD) constitutes a significant clinical challenge due to its complex etiology and patients’ difficulties in confronting traumatic experiences. The aim of this study is to analyze the effectiveness of virtual reality exposure therapy (VRET) as a modern alternative to classical therapeutic approaches and to evaluate its impact on patient engagement and the fear extinction process. This paper presents a review of current scientific literature, including randomized controlled trials, meta-analyses, and clinical guidelines (including APA recommendations) concerning the use of emerging technologies in trauma treatment. Particular attention is given to the comparison between VRET and traditional exposure methods, such as imaginal and in vivo exposure. The analysis indicates that VRET demonstrates effectiveness comparable to trauma-focused cognitive behavioral therapy (TF-CBT). A key advantage of VR is the high level of immersion and sense of presence, which facilitates emotional processing, particularly in patients who experience difficulties in visualizing traumatic events. Studies also suggest a tendency toward greater acceptance of this form of therapy among patients. Additionally, VRET shows strong potential for integration with adjunctive approaches, such as neuromodulation (tDCS) and physical activity (e.g., 3MDR). Virtual reality does not replace traditional therapeutic methods but rather represents a significant technological extension of them. Its primary advantages include precise personalization of exposure and increased control over the therapeutic process. The main barriers to widespread implementation of VRET remain the cost of equipment and the lack of standardized clinical protocols.